Accenture has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions for biopharma organizations across areas of science including precision medicine and diagnostics, oncology, cell & gene therapy, and rare diseases. Terms of the transaction were not disclosed.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ACN:
- Accenture awarded position on 10-year, $900M Air Force contract
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Accenture initiated with an Equal Weight at Wells Fargo
- Accenture invests in 3D holographic volumetric video tech firm Forma Vision
- Accenture makes strategic investment in optimization technology firm Cosmo Tech
